High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non‐small cell lung cancer

BACKGROUND: The treatment efficacy of immune checkpoint inhibitor (ICI) and clinical outcomes in patients with non‐small cell lung cancer (NSCLC) who develop severe grade checkpoint inhibitor pneumonitis (CIP) are unclear. Here, we report on the treatment efficacy of ICI and prognosis in NSCLC patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Tone, Mari, Izumo, Takehiro, Awano, Nobuyasu, Kuse, Naoyuki, Inomata, Minoru, Jo, Tatsunori, Yoshimura, Hanako, Minami, Jonsu, Takada, Kohei, Miyamoto, Shingo, Kunitoh, Hideo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6775002/
https://ncbi.nlm.nih.gov/pubmed/31482678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13187
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados